Select your language/region

Regulatory press release

2025/05/21

Q-linea announces outcome of the exercise of warrants of series TO1

Press release

2025/05/15

Today, 15 May 2025, is the last day of trading in warrants series TO 1 in Q-linea
Today, 15 May 2025, is the last day of trading in warrants series TO 1 in Q-linea AB (publ)...
Read more >

Press release

2025/05/15

The proposal by the nomination committee of Q-linea AB (publ) for election of members of the board of directors
The nomination committee of Q-linea AB (publ) submits the following proposals to be presented at the annual general meeting...
Read more >

Presentations

2025/05/09

Presentation – Redeye Theme: Medtech on May 8, 2025
Read more >

Upcoming Events

2025/05/07

Stuart Gander, CEO, Q-linea presents at Redeye Theme: Medtech

Press release

2025/04/29

Q-linea announces determined exercise price for warrants series TO 1 and update regarding subscription intentions
Q-linea AB (publ) (“Q-linea” or the “Company”) hereby announces that the exercise price for warrants series TO 1 (the...
Read more >

Regulatory press release

2025/04/28

Q-linea announces changes in executive leadership team

Regulatory press release

2025/04/25

Q-linea publish the Annual report for 2024
Q-linea AB (publ) (Nasdaq Stockholm: QLINEA), announced today that the Annual Report for the 2024 fiscal year has been...
Read more >

Regulatory press release

2025/04/16

Q-linea announces strong support of the TO1 warrant program as well as an extension of existing loan from large shareholder

Regulatory press release

2025/04/14

Interim report 1 January - 31 March 2025